Articles related to NEUROPLASTICITY

Amantadine emerges as the pharmacologic agent with the most support for improving cognitive impairment after TBI, while cognitive rehabilitation interventions demonstrate substantial evidence for enhancing neurocognitive function and reducing functional limitations.

Recent research suggests that promoting neuroplasticity through various techniques may offer new treatment possibilities for patients with neurodegenerative diseases, developmental disorders, and mental health conditions.

In this NEJM Double Take episode, experts discuss the critical role of neuroplasticity in depression and examine advanced treatment options for patients who do not respond to traditional therapies. Topics include the efficacy of ECT and TMS, as well as emerging evidence for ketamine, esketamine, and psilocybin.

Digital health technologies, including AI and virtual reality, are showing promise in addressing cognitive impairments, though challenges such as data security and accessibility remain. Early intervention and personalized treatment plans are becoming increasingly feasible, thanks to advancements in digital health.

In a landmark surgical endeavor, neurosurgeons have transferred sciatic nerve components from an amputated foot to the brachial plexus, showcasing the potential of neuroplasticity in restoring hand mobility.

Explore the paradigm shift in depression treatment from chemical imbalances to neuroplasticity, and discover how this emerging concept could revolutionize therapeutic approaches.